Translate Bio soars after expanding agreement to develop mRNA vaccines with Sanofi Pasteur Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Translate Bio (TBIO) up 55% after Sanofi Pasteur (SNY) and the company have agreed to expand their existing 2018 collaboration and license agreement to develop mRNA vaccines for infectious diseases
- Apyx Medical (APYX) up 23% after obtaining regulatory approval to market and sell its Helium Plasma Technology products in five new countries: Australia, Brazil, Israel, Taiwan and Thailand
- Myovant Sciences (MYOV) up 6% after its Relugolix combination therapy met its co-primary efficacy endpoints and all seven key secondary endpoints in the SPIRIT 1 study
- Starbucks (SBUX) up 1% after announcing the Impossible Breakfast Sandwich is available as part of its new summer menu
- New Residential (NRZ) up 6% after increasing its quarterly dividend to 10c per share
UP AFTER EARNINGS -
- Beyond Air (XAIR) up 1%
- W&T Offshore (WTI) up 5%
DOWN AFTER EARNINGS -
- Invesco Mortgage (IVR) down 1%
LOWER -
- American Airlines (AAL) down 6% after its 74.1M share secondary offering priced at $13.50 per share
- Spirit AeroSystems (SPR) down 3% after Boeing (BA) has directed the company to reduce its 2020 B737 production plan from 125 to 72 shipsets
- Cboe Global Markets (CBOE) down 2% after Goldman Sachs analyst Alexander Blostein downgraded shares to Sell from Neutral with a price target of $88, down from $100
- Micron (MU) down 1% after BMO Capital analyst Ambrish Srivastava downgraded the stock to Market Perform from Outperform with a price target of $55, down from $60
Symbols:
TBIO APYX MYOV SBUX NRZ XAIR WTI IVR AAL SPR CBOE MU Keywords: Fly Intel, Wall Street, Top Stories, Stocks